CD36 and cerebral malaria: In this issue of EMBO Molecular Medicine, Storm et al (2019) now used a micro‐channel flow adhesion assay to enquire how inhibition of iRBC cytoadhesion through blocking ICAM‐1, CD36 or EPCR on brain or dermal endothelial cells affects binding of parasites causing cerebral malaria or uncomplicated malaria.